Breaking News Instant updates and real-time market news.

AIRI

Air Industries

$2.83 /

+0.03 (+1.07%)

09:26
01/14/20
01/14
09:26
01/14/20
09:26

Air Industries trading halted, news pending

TODAY'S FREE FLY STORIES

Upgrade
Targa Resources upgraded to Buy from Hold at Stifel » 20:55
01/21/21
01/21
20:55
01/21/21
20:55
TRGP

Targa Resources

$28.75 /

-1.02 (-3.43%)

Stifel analyst Selman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRGP Targa Resources
$28.75 /

-1.02 (-3.43%)

TRGP Targa Resources
$28.75 /

-1.02 (-3.43%)

01/20/21 Mizuho
Targa Resources price target raised to $33 from $24 at Mizuho
01/13/21 JPMorgan
JPMorgan announces top 10 energy picks for 2021
01/13/21 Citi
Targa Resources price target raised to $36 from $22 at Citi
12/21/20 JPMorgan
Targa Resources price target raised to $37 from $33 at JPMorgan
TRGP Targa Resources
$28.75 /

-1.02 (-3.43%)

TRGP Targa Resources
$28.75 /

-1.02 (-3.43%)

Syndicate
Invitae 7.77M share Secondary priced at $51.50 » 20:42
01/21/21
01/21
20:42
01/21/21
20:42
NVTA

Invitae

$53.13 /

-3.75 (-6.59%)

The deal priced below the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVTA Invitae
$53.13 /

-3.75 (-6.59%)

NVTA Invitae
$53.13 /

-3.75 (-6.59%)

11/06/20 Ladenburg
Invitae downgraded to Neutral on valuation at Ladenburg
11/06/20 Ladenburg
Invitae downgraded to Neutral from Buy at Ladenburg
11/03/20 SVB Leerink
Invitae price target raised to $44 from $34 at SVB Leerink
10/14/20
Fly Intel: Top five analyst downgrades
NVTA Invitae
$53.13 /

-3.75 (-6.59%)

  • 22
    Jan
  • 02
    Apr
NVTA Invitae
$53.13 /

-3.75 (-6.59%)

NVTA Invitae
$53.13 /

-3.75 (-6.59%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
01/21/21
01/21
20:25
01/21/21
20:25
SLB

Schlumberger

$24.18 /

-1.16 (-4.58%)

, KSU

Kansas City Southern

$212.74 /

-2.92 (-1.35%)

, RF

Regions Financial

$17.81 /

-0.33 (-1.82%)

, ALLY

Ally Financial

$39.93 /

-1.43 (-3.46%)

, HBAN

Huntington Bancshares

$14.51 /

-0.18 (-1.23%)

, FHN

First Horizon

$14.34 /

-0.36 (-2.45%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Schlumberger (SLB), consensus 17c... Kansas City Southern (KSU), consensus $1.92... Regions Financial (RF), consensus 42c... Ally Financial (ALLY), consensus $1.05... Huntington Bancshares (HBAN), consensus 29c... First Horizon (FHN), consensus 33c.

ShowHide Related Items >><<
SLB Schlumberger
$24.18 /

-1.16 (-4.58%)

KSU Kansas City Southern
$212.74 /

-2.92 (-1.35%)

RF Regions Financial
$17.81 /

-0.33 (-1.82%)

ALLY Ally Financial
$39.93 /

-1.43 (-3.46%)

HBAN Huntington Bancshares
$14.51 /

-0.18 (-1.23%)

FHN First Horizon
$14.34 /

-0.36 (-2.45%)

SLB Schlumberger
$24.18 /

-1.16 (-4.58%)

12/18/20 JPMorgan
Schlumberger price target raised to $21 from $19 at JPMorgan
12/15/20 Citi
Schlumberger price target raised to $30 from $25 at Citi
12/10/20 HSBC
Schlumberger downgraded to Reduce from Hold at HSBC
11/30/20 Susquehanna
Susquehanna raises targets across Oilfield Services on cyclical rebound
KSU Kansas City Southern
$212.74 /

-2.92 (-1.35%)

01/15/21 Raymond James
Kansas City Southern price target raised to $245 from $210 at Raymond James
01/12/21 JPMorgan
Kansas City Southern price target raised to $204 from $199 at JPMorgan
01/11/21 Citi
Kansas City Southern price target raised to $250 from $220 at Citi
12/10/20 Morgan Stanley
Morgan Stanley downgrades CSX to Underweight with bar raised too high
RF Regions Financial
$17.81 /

-0.33 (-1.82%)

01/15/21 Compass Point
Regions Financial upgraded to Buy from Neutral at Compass Point
01/12/21 UBS
UBS downgrades Citizens on revenue headwinds, Wells new top pick
01/07/21 Keefe Bruyette
Regions Financial upgraded to Outperform from Market Perform at Keefe Bruyette
01/07/21 Baird
Regions Financial downgraded to Neutral from Outperform at Baird
ALLY Ally Financial
$39.93 /

-1.43 (-3.46%)

01/19/21 JPMorgan
Ally Financial price target raised to $47 from $32 at JPMorgan
01/13/21 Janney Montgomery Scott
Ally Financial price target raised to $45 from $40 at Janney Montgomery Scott
01/13/21 Credit Suisse
Ally Financial price target raised to $42 from $34 at Credit Suisse
01/13/21 Citi
Ally Financial price target raised to $45 from $33 at Citi
HBAN Huntington Bancshares
$14.51 /

-0.18 (-1.23%)

01/13/21 Piper Sandler
PNC Financial downgraded to Neutral from Overweight at Piper Sandler
01/06/21 Wedbush
Huntington Bancshares added to Best Ideas List at Wedbush
01/06/21 Deutsche Bank
Huntington Bancshares price target raised to $14 from $10.50 at Deutsche Bank
01/05/21 Piper Sandler
TCF Financial upgraded to Overweight from Neutral at Piper Sandler
FHN First Horizon
$14.34 /

-0.36 (-2.45%)

10/08/20 Jefferies
First Horizon upgraded to Buy from Hold at Jefferies
09/22/20 Raymond James
First Horizon upgraded to Strong Buy from Outperform at Raymond James
08/20/20 Goldman Sachs
First Horizon reinstated with a Buy at Goldman Sachs
08/17/20 Morgan Stanley
First Horizon resumed with an Equal Weight at Morgan Stanley
SLB Schlumberger
$24.18 /

-1.16 (-4.58%)

KSU Kansas City Southern
$212.74 /

-2.92 (-1.35%)

RF Regions Financial
$17.81 /

-0.33 (-1.82%)

ALLY Ally Financial
$39.93 /

-1.43 (-3.46%)

HBAN Huntington Bancshares
$14.51 /

-0.18 (-1.23%)

FHN First Horizon
$14.34 /

-0.36 (-2.45%)

SLB Schlumberger
$24.18 /

-1.16 (-4.58%)

KSU Kansas City Southern
$212.74 /

-2.92 (-1.35%)

RF Regions Financial
$17.81 /

-0.33 (-1.82%)

HBAN Huntington Bancshares
$14.51 /

-0.18 (-1.23%)

SLB Schlumberger
$24.18 /

-1.16 (-4.58%)

KSU Kansas City Southern
$212.74 /

-2.92 (-1.35%)

RF Regions Financial
$17.81 /

-0.33 (-1.82%)

ALLY Ally Financial
$39.93 /

-1.43 (-3.46%)

HBAN Huntington Bancshares
$14.51 /

-0.18 (-1.23%)

FHN First Horizon
$14.34 /

-0.36 (-2.45%)

SLB Schlumberger
$24.18 /

-1.16 (-4.58%)

KSU Kansas City Southern
$212.74 /

-2.92 (-1.35%)

RF Regions Financial
$17.81 /

-0.33 (-1.82%)

ALLY Ally Financial
$39.93 /

-1.43 (-3.46%)

HBAN Huntington Bancshares
$14.51 /

-0.18 (-1.23%)

FHN First Horizon
$14.34 /

-0.36 (-2.45%)

Syndicate
Passage Bio 7M share Secondary priced at $22.00 » 19:53
01/21/21
01/21
19:53
01/21/21
19:53
PASG

Passage Bio

$22.84 /

-4.3 (-15.84%)

The deal priced below the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$22.84 /

-4.3 (-15.84%)

PASG Passage Bio
$22.84 /

-4.3 (-15.84%)

01/04/21 Chardan
Lifting hold on PGBM01 a 'broad positive' for Passage Bio pipeline, says Chardan
01/04/21 JPMorgan
Passage Bio upgraded to Overweight at JPMorgan after clinical hold lifted
01/04/21 JPMorgan
Passage Bio upgraded to Overweight from Neutral at JPMorgan
12/11/20 Citi
Passage Bio initiated with a Neutral at Citi
PASG Passage Bio
$22.84 /

-4.3 (-15.84%)

  • 22
    Jan
  • 28
    Feb
PASG Passage Bio
$22.84 /

-4.3 (-15.84%)

Hot Stocks
Aclaris gets orphan drug designation in cryopyrin-associated periodic syndrome » 19:50
01/21/21
01/21
19:50
01/21/21
19:50
ACRS

Aclaris Therapeutics

$18.11 /

+0.28 (+1.57%)

Aclaris announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$18.11 /

+0.28 (+1.57%)

ACRS Aclaris Therapeutics
$18.11 /

+0.28 (+1.57%)

01/19/21 William Blair
Aclaris has potential in range of 'blockbuster indications,' says William Blair
ACRS Aclaris Therapeutics
$18.11 /

+0.28 (+1.57%)

  • 20
    Jan
ACRS Aclaris Therapeutics
$18.11 /

+0.28 (+1.57%)

Hot Stocks
Novartis Gene Therapies gets FDA Orphan Drug Designation in Friedreich's Ataxia » 19:48
01/21/21
01/21
19:48
01/21/21
19:48
NVS

Novartis

$96.83 /

-0.085 (-0.09%)

Novartis Gene Therapies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$96.83 /

-0.085 (-0.09%)

NVS Novartis
$96.83 /

-0.085 (-0.09%)

01/15/21 Deutsche Bank
Novartis initiated with a Buy at Deutsche Bank
01/12/21 Piper Sandler
BeiGene price target raised to $190 from $185 at Piper Sandler
01/08/21 Morgan Stanley
Novartis price target raised to CHF 104 from CHF 102 at Morgan Stanley
01/08/21 Morgan Stanley
Roche downgraded to Equal Weight from Overweight at Morgan Stanley
NVS Novartis
$96.83 /

-0.085 (-0.09%)

NVS Novartis
$96.83 /

-0.085 (-0.09%)

NVS Novartis
$96.83 /

-0.085 (-0.09%)

Syndicate
BJ's Restaurants announces at-the-market equity program for $25M » 19:46
01/21/21
01/21
19:46
01/21/21
19:46
BJRI

BJ's Restaurants

$46.22 /

-1.17 (-2.47%)

The company currently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BJRI BJ's Restaurants
$46.22 /

-1.17 (-2.47%)

BJRI BJ's Restaurants
$46.22 /

-1.17 (-2.47%)

07:26 Today Deutsche Bank
BJ's Restaurants downgraded to Hold after 42% rally at Deutsche Bank
01/20/21 Deutsche Bank
BJ's Restaurants downgraded to Hold from Buy at Deutsche Bank
01/07/21 Stephens
BJ's Restaurants upgraded to Overweight on casual dining 'boom' at Stephens
01/07/21 Stephens
BJ's Restaurants upgraded to Overweight from Equal Weight at Stephens
BJRI BJ's Restaurants
$46.22 /

-1.17 (-2.47%)

BJRI BJ's Restaurants
$46.22 /

-1.17 (-2.47%)

Earnings
BJ's Restaurants sees Q4 revenue $197.0M, consensus $210.97M » 19:45
01/21/21
01/21
19:45
01/21/21
19:45
BJRI

BJ's Restaurants

$46.22 /

-1.17 (-2.47%)

Sees Q4 SSS down 32.3%. …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BJRI BJ's Restaurants
$46.22 /

-1.17 (-2.47%)

BJRI BJ's Restaurants
$46.22 /

-1.17 (-2.47%)

07:26 Today Deutsche Bank
BJ's Restaurants downgraded to Hold after 42% rally at Deutsche Bank
01/20/21 Deutsche Bank
BJ's Restaurants downgraded to Hold from Buy at Deutsche Bank
01/07/21 Stephens
BJ's Restaurants upgraded to Overweight on casual dining 'boom' at Stephens
01/07/21 Stephens
BJ's Restaurants upgraded to Overweight from Equal Weight at Stephens
BJRI BJ's Restaurants
$46.22 /

-1.17 (-2.47%)

BJRI BJ's Restaurants
$46.22 /

-1.17 (-2.47%)

Hot Stocks
Amgen granted FDA Orphan Drug Designation for carfilzomib » 19:41
01/21/21
01/21
19:41
01/21/21
19:41
AMGN

Amgen

$252.13 /

-0.28 (-0.11%)

Amgen announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$252.13 /

-0.28 (-0.11%)

AMGN Amgen
$252.13 /

-0.28 (-0.11%)

12/29/20 Daiwa
Amgen initiated with a Buy at Daiwa
12/28/20 Oppenheimer
Amgen price target lowered to $266 from $274 at Oppenheimer
12/15/20 Goldman Sachs
Amgen downgraded to Buy from Conviction Buy at Goldman Sachs
12/09/20 SVB Leerink
Amgen price target raised to $253 from $243 at SVB Leerink
AMGN Amgen
$252.13 /

-0.28 (-0.11%)

AMGN Amgen
$252.13 /

-0.28 (-0.11%)

AMGN Amgen
$252.13 /

-0.28 (-0.11%)

AMGN Amgen
$252.13 /

-0.28 (-0.11%)

Initiation
Autodesk initiated with a Sell at Goldman Sachs » 18:55
01/21/21
01/21
18:55
01/21/21
18:55
ADSK

Autodesk

$306.43 /

-2.24 (-0.73%)

Goldman Sachs analyst…

Goldman Sachs analyst Kash Rangan initiated coverage of Autodesk with a Sell rating and $270 price target. The company is a "category leader" and looks poised to grow into a dominant design, automation software company in the cloud in key end markets including architecture, engineering, construction, and manufacturing, the analyst tells investors in a research note. Rangan is concerned however that the health of Autodesk's end markets remains uncertain, adding that the company's medium-term revenue and free cash flow targets are "increasingly back end loaded".

ShowHide Related Items >><<
ADSK Autodesk
$306.43 /

-2.24 (-0.73%)

ADSK Autodesk
$306.43 /

-2.24 (-0.73%)

01/15/21 Deutsche Bank
Autodesk price target raised to $370 from $300 at Deutsche Bank
01/06/21 Barclays
Autodesk price target raised to $324 from $295 at Barclays
01/05/21 KeyBanc
Autodesk price target raised to $345 from $310 at KeyBanc
12/16/20 Mizuho
Autodesk price target raised to $340 from $290 at Mizuho
ADSK Autodesk
$306.43 /

-2.24 (-0.73%)

ADSK Autodesk
$306.43 /

-2.24 (-0.73%)

ADSK Autodesk
$306.43 /

-2.24 (-0.73%)

Initiation
Oracle initiated with a Sell at Goldman Sachs » 18:53
01/21/21
01/21
18:53
01/21/21
18:53
ORCL

Oracle

$61.19 /

-0.36 (-0.58%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORCL Oracle
$61.19 /

-0.36 (-0.58%)

ORCL Oracle
$61.19 /

-0.36 (-0.58%)

12/18/20
Fly Intel: Top five analyst upgrades
12/18/20 Monness Crespi
Monness Crespi upgrades 'value play' Oracle to Buy with $82 price target
12/18/20 Monness Crespi
Oracle upgraded to Buy from Neutral at Monness Crespi
12/17/20 Rosenblatt
LivePerson initiated with a Buy at Rosenblatt
ORCL Oracle
$61.19 /

-0.36 (-0.58%)

ORCL Oracle
$61.19 /

-0.36 (-0.58%)

ORCL Oracle
$61.19 /

-0.36 (-0.58%)

ORCL Oracle
$61.19 /

-0.36 (-0.58%)

Initiation
VMware initiated with a Neutral at Goldman Sachs » 18:52
01/21/21
01/21
18:52
01/21/21
18:52
VMW

VMware

$134.09 /

+1.46 (+1.10%)

Goldman Sachs analyst…

Goldman Sachs analyst Kash Rangan initiated coverage of VMware with a Neutral rating and $150 price target. The analyst is confident the company can hit a $20B revenue target, though there are "several" near-term headwinds. Rangan added that VMware is the "most successful" infrastructure software company to have attained scale and profitability.

ShowHide Related Items >><<
VMW VMware
$134.09 /

+1.46 (+1.10%)

VMW VMware
$134.09 /

+1.46 (+1.10%)

09:54 Today
Fly Intel: Top five analyst downgrades
07:21 Today KeyBanc
KeyBanc cuts VMware to Sector Weight ahead of 'more challenging first half'
06:00 Today KeyBanc
VMware downgraded to Sector Weight from Overweight at KeyBanc
01/15/21 Evercore ISI
Evercore adds Dell Technologies to tactical Outperform list, ups target to $85
VMW VMware
$134.09 /

+1.46 (+1.10%)

VMW VMware
$134.09 /

+1.46 (+1.10%)

VMW VMware
$134.09 /

+1.46 (+1.10%)

VMW VMware
$134.09 /

+1.46 (+1.10%)

Initiation
Snowflake initiated with a Neutral at Goldman Sachs » 18:51
01/21/21
01/21
18:51
01/21/21
18:51
SNOW

Snowflake

$285.91 /

+4.05 (+1.44%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNOW Snowflake
$285.91 /

+4.05 (+1.44%)

SNOW Snowflake
$285.91 /

+4.05 (+1.44%)

01/19/21 Rosenblatt
Snowflake initiated with a Neutral at Rosenblatt
01/15/21 Credit Suisse
Snowflake price target raised to $310 from $265 at Credit Suisse
01/13/21 Citi
Snowflake price target raised to $325 from $300 at Citi
01/05/21 Deutsche Bank
Deutsche cuts Snowflake target with upcoming lockup adding 87% to float
SNOW Snowflake
$285.91 /

+4.05 (+1.44%)

  • 16
    Sep
SNOW Snowflake
$285.91 /

+4.05 (+1.44%)

SNOW Snowflake
$285.91 /

+4.05 (+1.44%)

SNOW Snowflake
$285.91 /

+4.05 (+1.44%)

Initiation
Elastic initiated with a Neutral at Goldman Sachs » 18:50
01/21/21
01/21
18:50
01/21/21
18:50
ESTC

Elastic

$171.40 /

+2.57 (+1.52%)

Goldman Sachs analyst…

Goldman Sachs analyst Kash Rangan initiated coverage of Elastic with a Neutral rating and $190 price target. The analyst said his price target is based on the firm's fundamental valuation framework, adding that his thesis is that Elastic's combination of technology and differentiated customer approach has the potential to disrupt the "fragmented" IT Operations market.

ShowHide Related Items >><<
ESTC Elastic
$171.40 /

+2.57 (+1.52%)

ESTC Elastic
$171.40 /

+2.57 (+1.52%)

01/19/21 Truist
Elastic initiated with a Buy at Truist
01/15/21 Stifel
Elastic upgraded to Buy after licensing changes at Stifel
01/14/21 Stifel
Elastic upgraded to Buy from Hold at Stifel
01/13/21 Citi
Elastic price target raised to $190 from $160 at Citi
ESTC Elastic
$171.40 /

+2.57 (+1.52%)

ESTC Elastic
$171.40 /

+2.57 (+1.52%)

Initiation
Intuit assumed with a Neutral at Goldman Sachs » 18:49
01/21/21
01/21
18:49
01/21/21
18:49
INTU

Intuit

$381.68 /

-7.99 (-2.05%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INTU Intuit
$381.68 /

-7.99 (-2.05%)

INTU Intuit
$381.68 /

-7.99 (-2.05%)

01/19/21 Wells Fargo
Intuit price target raised to $440 from $425 at Wells Fargo
01/11/21 Barclays
Intuit reinstated with an Overweight at Barclays
12/22/20 Citi
Intuit price target raised to $383 from $378 at Citi
12/11/20 Goldman Sachs
Intuit reinstated with a Neutral at Goldman Sachs
INTU Intuit
$381.68 /

-7.99 (-2.05%)

  • 09
    Dec
INTU Intuit
$381.68 /

-7.99 (-2.05%)

INTU Intuit
$381.68 /

-7.99 (-2.05%)

INTU Intuit
$381.68 /

-7.99 (-2.05%)

Initiation
ServiceNow assumed with a Buy at Goldman Sachs » 18:47
01/21/21
01/21
18:47
01/21/21
18:47
NOW

ServiceNow

$544.83 /

+2.545 (+0.47%)

Goldman Sachs analyst…

Goldman Sachs analyst Kash Rangan assumed coverage of ServiceNow with a Buy rating and $670 price target. The company stands "well positioned" to become an over $15B revenue cloud applications software firm by 2026, the analyst tells investors in a research note. Rangan adds that ServiceNow's operating margins could then hit 30%-35% and free cash flow margins could potentially reach 35%-40% thanks to its "very efficient" customer acquisition economics and expansion beyond its core ITSM market into adjacent markets.

ShowHide Related Items >><<
NOW ServiceNow
$544.83 /

+2.545 (+0.47%)

NOW ServiceNow
$544.83 /

+2.545 (+0.47%)

01/14/21 Oppenheimer
ServiceNow upgraded to Outperform at Oppenheimer on glide path to $10B in sales
01/14/21 Oppenheimer
ServiceNow upgraded to Outperform from Perform at Oppenheimer
01/05/21 Piper Sandler
ServiceNow price target raised to $550 from $500 at Piper Sandler
12/16/20 Mizuho
ServiceNow price target raised to $600 from $570 at Mizuho
NOW ServiceNow
$544.83 /

+2.545 (+0.47%)

NOW ServiceNow
$544.83 /

+2.545 (+0.47%)

Initiation
Splunk assumed with a Buy at Goldman Sachs » 18:46
01/21/21
01/21
18:46
01/21/21
18:46
SPLK

Splunk

$171.78 /

-0.89 (-0.52%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$171.78 /

-0.89 (-0.52%)

SPLK Splunk
$171.78 /

-0.89 (-0.52%)

12/29/20 Daiwa
Daiwa takes 'wait-and-see posture' on Splunk, starts with Neutral
12/28/20 Daiwa
Splunk initiated with a Neutral at Daiwa
12/17/20 Rosenblatt
Splunk initiated with Buy, $196 price target at Rosenblatt
12/16/20 Rosenblatt
Splunk initiated with a Buy at Rosenblatt
SPLK Splunk
$171.78 /

-0.89 (-0.52%)

SPLK Splunk
$171.78 /

-0.89 (-0.52%)

SPLK Splunk
$171.78 /

-0.89 (-0.52%)

SPLK Splunk
$171.78 /

-0.89 (-0.52%)

Hot Stocks
Blue Ridge Bankshares and Bay Banks of Virginia shareholders approve merger » 18:45
01/21/21
01/21
18:45
01/21/21
18:45
BRBS

Blue Ridge Bankshares

$19.90 /

+0.4 (+2.05%)

Blue Ridge Bankshares and…

Blue Ridge Bankshares and Bay Banks of Virginia shareholders approved the previously announced merger of Bay Banks into Blue Ridge. The combined company would have approximately $2.8B in assets, $1.9B in deposits, and $2.1B in loans.

ShowHide Related Items >><<
BRBS Blue Ridge Bankshares
$19.90 /

+0.4 (+2.05%)

Initiation
Adobe initiated with a Buy at Goldman Sachs » 18:44
01/21/21
01/21
18:44
01/21/21
18:44
ADBE

Adobe

$472.07 /

+2.185 (+0.47%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$472.07 /

+2.185 (+0.47%)

ADBE Adobe
$472.07 /

+2.185 (+0.47%)

01/13/21 Stifel
Adobe transferred with Buy rating at Stifel
12/11/20 BMO Capital
Adobe price target raised to $570 from $560 at BMO Capital
12/11/20 RBC Capital
Adobe price target raised to $575 from $570 at RBC Capital
12/10/20 Oppenheimer
Adobe reports 'good' results, fundamentals remain solid, says Oppenheimer
ADBE Adobe
$472.07 /

+2.185 (+0.47%)

ADBE Adobe
$472.07 /

+2.185 (+0.47%)

ADBE Adobe
$472.07 /

+2.185 (+0.47%)

ADBE Adobe
$472.07 /

+2.185 (+0.47%)

Initiation
Workday initiated with a Buy at Goldman Sachs » 18:44
01/21/21
01/21
18:44
01/21/21
18:44
WDAY

Workday

$229.50 /

+3 (+1.32%)

Goldman Sachs analyst…

Goldman Sachs analyst Kash Rangan initiated coverage of Workday with a Buy rating and $300 price target. The company is a "uniquely positioned application software company addressing massive cloud replacement cycles in an over $90B total addressable market" and spans human capital resources, financials, analytics, planning, and procurement, the analyst tells investors in a research note. Workday is poised to grow into an over $10B business catalyzed by financials moving to the cloud following its core HCM marquee product, Rangan adds.

ShowHide Related Items >><<
WDAY Workday
$229.50 /

+3 (+1.32%)

WDAY Workday
$229.50 /

+3 (+1.32%)

01/11/21 Piper Sandler
Bill.com price target raised to $140 from $120 at Piper Sandler
12/16/20 BofA
Workday reinstated with a Buy at BofA
12/16/20 BofA
Workday reinstated with a Buy at BofA
11/25/20 Jefferies
Anaplan price target raised to $70 from $65 at Jefferies
WDAY Workday
$229.50 /

+3 (+1.32%)

WDAY Workday
$229.50 /

+3 (+1.32%)

WDAY Workday
$229.50 /

+3 (+1.32%)

Initiation
Salesforce initiated with a Buy at Goldman Sachs » 18:42
01/21/21
01/21
18:42
01/21/21
18:42
CRM

Salesforce

$222.20 /

-1.29 (-0.58%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$222.20 /

-1.29 (-0.58%)

CRM Salesforce
$222.20 /

-1.29 (-0.58%)

01/15/21 Credit Suisse
Salesforce price target raised to $260 from $245 at Credit Suisse
01/11/21 Piper Sandler
Salesforce downgraded to Neutral from Overweight at Piper Sandler
12/17/20 Rosenblatt
LivePerson initiated with a Buy at Rosenblatt
12/16/20 BofA
Salesforce reinstated with a Buy at BofA
CRM Salesforce
$222.20 /

-1.29 (-0.58%)

CRM Salesforce
$222.20 /

-1.29 (-0.58%)

CRM Salesforce
$222.20 /

-1.29 (-0.58%)

CRM Salesforce
$222.20 /

-1.29 (-0.58%)

Initiation
Microsoft initiated with a Buy at Goldman Sachs » 18:39
01/21/21
01/21
18:39
01/21/21
18:39
MSFT

Microsoft

$224.90 /

+0.61 (+0.27%)

Goldman Sachs analyst…

Goldman Sachs analyst Kash Rangan initiated coverage of Microsoft with a Buy rating and $285 price target. The company stands out "uniquely" with its presence across all layers of the cloud stack, the analyst tells investors in a research note. Rangan adds that Microsoft is well positioned to double its $60B commercial cloud business which includes Azure, Office 365, Dynamics, and LinkedIn Commercial into a $120B-$140B business longer term. The analyst further states that Office 365 could potentially double its installed base from over 255M to 500M given the massive number of knowledge workers worldwide.

ShowHide Related Items >><<
MSFT Microsoft
$224.90 /

+0.61 (+0.27%)

MSFT Microsoft
$224.90 /

+0.61 (+0.27%)

09:36 Today Cleveland Research
Microsoft demand beat expectations in December quarter, says Cleveland Research
08:30 Today Evercore ISI
Evercore boosts Microsoft target, adds to 'tactical outperform list'
06:37 Today Citi
Citi sees positive setup around key Microsoft metrics into results
01/20/21 JPMorgan
JPMorgan boosts GM target to $63, calls 'significant contender' in autonomous
MSFT Microsoft
$224.90 /

+0.61 (+0.27%)

MSFT Microsoft
$224.90 /

+0.61 (+0.27%)

MSFT Microsoft
$224.90 /

+0.61 (+0.27%)

MSFT Microsoft
$224.90 /

+0.61 (+0.27%)

On The Fly
Fly Intel: After-Hours Movers » 18:35
01/21/21
01/21
18:35
01/21/21
18:35
SIVB

SVB Financial

$455.02 /

-7.49 (-1.62%)

, WAL

Western Alliance

$69.40 /

-1.92 (-2.69%)

, INDB

Independent Bank

$78.68 /

-1.39 (-1.74%)

, OZK

Bank OZK

$34.03 /

-0.59 (-1.70%)

, FLDM

Fluidigm

$6.17 /

+0.31 (+5.29%)

, MNOV

MediciNova

$5.78 /

+0.09 (+1.58%)

, SWIR

Sierra Wireless

$18.41 /

+0.02 (+0.11%)

, ALDX

Aldeyra

$11.77 /

-0.48 (-3.92%)

, AMRN

Amarin

$6.31 /

+0.11 (+1.78%)

, IBM

IBM

$131.80 /

+1.72 (+1.32%)

, STX

Seagate

$63.00 /

+1.57 (+2.56%)

, PPG

PPG

$143.94 /

-0.635 (-0.44%)

, ISRG

Intuitive Surgical

$799.43 /

-0.18 (-0.02%)

, CSX

CSX

$91.61 /

-1.6101 (-1.73%)

, PGEN

Precigen

$9.18 /

-0.22 (-2.34%)

, ACB

Aurora Cannabis

$11.17 /

-0.39 (-3.37%)

, F

Ford

$11.53 /

+0.665 (+6.12%)

Check out this evening's…

ShowHide Related Items >><<
SWIR Sierra Wireless
$18.41 /

+0.02 (+0.11%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

PGEN Precigen
$9.18 /

-0.22 (-2.34%)

OZK Bank OZK
$34.03 /

-0.59 (-1.70%)

MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

01/08/21 Oppenheimer
Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move'
01/05/21 DA Davidson
SVB Financial price target raised to $400 from $365 at DA Davidson
01/05/21 Raymond James
SVB Financial price target raised to $440 from $325 at Raymond James
01/05/21 RBC Capital
SVB Financial price target raised to $437 from $320 at RBC Capital
WAL Western Alliance
$69.40 /

-1.92 (-2.69%)

01/08/21 UBS
Western Alliance upgraded to Buy from Neutral at UBS
01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
12/15/20 Truist
Truist raises price targets on select regional banks
11/04/20 Stephens
Western Alliance resumed with an Overweight at Stephens
INDB Independent Bank
$78.68 /

-1.39 (-1.74%)

12/17/20 Seaport Global
Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys
12/17/20 Seaport Global
Independent Bank initiated with a Neutral at Seaport Global
10/26/20 Compass Point
Independent Bank upgraded to Buy from Neutral at Compass Point
06/24/20 Piper Sandler
Independent Bank downgraded to Neutral from Overweight at Piper Sandler
OZK Bank OZK
$34.03 /

-0.59 (-1.70%)

06/17/20 Raymond James
Bank OZK upgraded to Outperform from Market Perform at Raymond James
06/17/20 Citi
Bank OZK downgraded to Neutral from Buy at Citi
06/17/20 Raymond James
Bank OZK upgraded to Outperform from Market Perform at Raymond James
04/28/20 Truist
Bank OZK price target raised to $22 from $19 at SunTrust
FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
10/19/20 Piper Sandler
Fluidigm test pact in Texas 'another validation,' says Piper Sandler
09/29/20 Piper Sandler
Piper Sandler would be buyers of Fluidigm given recent pullback
MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

SWIR Sierra Wireless
$18.41 /

+0.02 (+0.11%)

01/14/21
Fly Intel: Top five analyst initiations
01/14/21 B. Riley Securities
Sierra Wireless initiated with a Buy at B. Riley Securities
11/25/20 Colliers
Sierra Wireless initiated with a Buy at Colliers
02/14/20 Roth Capital
Roth Capital sees upside in Sierra Wireless after 2020 transition year
ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

01/08/21 Jefferies
Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
01/08/21 Citi
Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
01/07/21 Alliance Global Partners
Aldeyra in an 'enviable position' after Phase 3 Tranquility data, says AGP
12/16/20 Berenberg
Berenberg starts Aldeyra with Buy, sees near-term catalysts
AMRN Amarin
$6.31 /

+0.11 (+1.78%)

01/08/21 Piper Sandler
Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target
12/28/20 Cantor Fitzgerald
Vascepa showing positive year-over-year trends, says Cantor Fitzgerald
12/23/20 Goldman Sachs
Amarin price target lowered to $6 from $8 at Goldman Sachs
12/14/20 Piper Sandler
Amarin's Vascepa showed 'encouraging results' in Covid patients, says Piper
IBM IBM
$131.80 /

+1.72 (+1.32%)

10/20/20 Morgan Stanley
Morgan Stanley continues to view IBM as 'a 2022 stock'
10/20/20 Citi
IBM is 'getting even more complex,' says Citi
10/20/20 BMO Capital
IBM price target lowered to $138 from $140 at BMO Capital
10/09/20 Morgan Stanley
IBM price target raised to $140 from $128 at Morgan Stanley
STX Seagate
$63.00 /

+1.57 (+2.56%)

07:08 Today Barclays
Seagate price target raised to $60 from $41 at Barclays
01/20/21 Wedbush
Seagate price target raised to $56 from $47 at Wedbush
01/19/21 Northland
Seagate price target raised to $72 from $65 at Northland
01/19/21 Loop Capital
Seagate price target raised to $70 from $60 at Loop Capital
PPG PPG
$143.94 /

-0.635 (-0.44%)

01/20/21 Citi
Citi adds PPG to US Focus List, removes FMC
01/14/21 Berenberg
PPG upgraded to Buy with $165 price target at Berenberg
01/14/21 Berenberg
PPG upgraded to Buy from Hold at Berenberg
12/01/20 Deutsche Bank
PPG price target raised to $165 from $155 at Deutsche Bank
ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

12/15/20 Morgan Stanley
Intuitive Surgical downgraded to Equal Weight on valuation at Morgan Stanley
12/15/20 Morgan Stanley
Intuitive Surgical downgraded to Equal Weight from Overweight at Morgan Stanley
11/24/20 Raymond James
Intuitive Surgical not surprised by J&J robot features, says Raymond James
10/16/20 JPMorgan
Intuitive Surgical price target raised to $785 from $765 at JPMorgan
CSX CSX
$91.61 /

-1.6101 (-1.73%)

01/20/21 Susquehanna
Railroad recovery expected to continue in 2021, says Susquehanna
01/11/21 Citi
CSX price target raised to $105 from $87 at Citi
12/10/20 Morgan Stanley
Morgan Stanley downgrades CSX to Underweight with bar raised too high
12/10/20 Morgan Stanley
CSX downgraded to Underweight from Equal Weight at Morgan Stanley
PGEN Precigen
$9.18 /

-0.22 (-2.34%)

12/16/20 H.C. Wainwright
Precigen price target raised to $10 from $8 at H.C. Wainwright
05/08/20
Fly Intel: Top analyst initiations
05/08/20 H.C. Wainwright
Precigen initiated with a Buy at H.C. Wainwright
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
12/17/20 BMO Capital
Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
F Ford
$11.53 /

+0.665 (+6.12%)

01/20/21 Deutsche Bank
Ford price target raised to $11 from $9 at Deutsche Bank
01/20/21 Deutsche Bank
Ford named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
12/23/20 Morgan Stanley
Apple's potential EV entry represents 'new Tesla bear case,' says Morgan Stanley
WAL Western Alliance
$69.40 /

-1.92 (-2.69%)

SWIR Sierra Wireless
$18.41 /

+0.02 (+0.11%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

PGEN Precigen
$9.18 /

-0.22 (-2.34%)

OZK Bank OZK
$34.03 /

-0.59 (-1.70%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

INDB Independent Bank
$78.68 /

-1.39 (-1.74%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

  • 22
    Jan
  • 22
    Jan
  • 14
    Jan
  • 11
    Nov
IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

PGEN Precigen
$9.18 /

-0.22 (-2.34%)

MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

Hot Stocks
Amarin announces CSC included icosapent ethyl in CD prevention guidelines » 18:27
01/21/21
01/21
18:27
01/21/21
18:27
AMRN

Amarin

$6.31 /

+0.11 (+1.78%)

The company states:…

The company states: "Amarin announced that the Chinese Society of Cardiology, or CSC, has included icosapent ethyl in its updated Guidelines for Primary Prevention of Cardiovascular Diseases for 2021 as published in the Chinese Journal of Cardiovascular Diseases. The guideline authors include "icosapent ethyl grams twice a day as a treatment consideration to further lower atherosclerotic cardiovascular disease (ASCVD) in the appropriate patient population. In November 2020, Amarin shared positive, statistically significant top-line results from a Phase 3 clinical trial of VASCEPA conducted in China by Amarin's partner, Edding. The study, which investigated VASCEPA as a treatment for patients with very high triglycerides (greater than or equal to500 mg/dL), met its primary efficacy endpoint and demonstrated a safety profile similar to placebo. This pivotal study mirrored Amarin's MARINE study in patients from the United States and other countries and showed consistency across the Chinese and non-Chinese study populations. These findings will provide support as Edding progresses towards and through the next steps of regulatory submission and review of VASCEPA for potential approval in Mainland China. The CSC recommendation is classified as a Category IIa recommendation denoting that icosapent ethyl is useful and effective and should be considered for treatment of at-risk patients. The classification is an Evidence Level B recommendation which reflects that the evidence comes from a single randomized trial or multiple large non-randomized studies. CSC cited that its recommendations are supported by the results of the REDUCE-IT cardiovascular outcomes study. The CSC does not provide endorsements of any brand name commercial product. Accordingly, CSC Guidelines for Primary Prevention of Cardiovascular Diseases reference icosapent ethyl. The CSC guideline does not reference VASCEPA, the brand name of icosapent ethyl in the United States, and such guideline should not be construed as an endorsement or approval by the CSC of VASCEPA."

ShowHide Related Items >><<
AMRN Amarin
$6.31 /

+0.11 (+1.78%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

01/08/21 Piper Sandler
Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target
12/28/20 Cantor Fitzgerald
Vascepa showing positive year-over-year trends, says Cantor Fitzgerald
12/23/20 Goldman Sachs
Amarin price target lowered to $6 from $8 at Goldman Sachs
12/14/20 Piper Sandler
Amarin's Vascepa showed 'encouraging results' in Covid patients, says Piper
AMRN Amarin
$6.31 /

+0.11 (+1.78%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

Hot Stocks
Aldeyra rises 6% after 1.37M share purchase disclosed by Perceptive Advisors » 18:25
01/21/21
01/21
18:25
01/21/21
18:25
ALDX

Aldeyra

$11.77 /

-0.48 (-3.92%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

01/08/21 Jefferies
Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
01/08/21 Citi
Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
01/07/21 Alliance Global Partners
Aldeyra in an 'enviable position' after Phase 3 Tranquility data, says AGP
12/16/20 Berenberg
Berenberg starts Aldeyra with Buy, sees near-term catalysts
ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

  • 14
    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.